More Imagion Biosystems Ltd. news
Imagion Biosystems Ltd.ASX: IBX

Imagion Biosystems HER2 Breast Cancer Program Update

Oct 6, 2025 at 11:07 PM EDT · Issued by Imagion Biosystems Ltd.

Filed with ASX · Oct 6, 2025 at 11:07 PM EDT

On 6ix: 6ix.com/news/imagion-biosystems-her2-breast-cancer-program-update

Imagion Biosystems Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Imagion Biosystems Ltd. on 6ix

Story so far

  • Imagion MagSense Breast Cancer Program Phase 2 Trial UpdateJul 15, 2025
  • Positive clinical data reported at breast cancer symposiumDec 8, 2022

Earlier from Imagion Biosystems

  • Ph2 Manufacturing & Imaging Optimisation Activities CommenceSep 7, 2025
  • Appendix 4D and Half-yearly Financial ReportAug 27, 2025
  • IBX Secures Firm Commitments for A$3.5m Capital RaisingAug 3, 2025
  • Trading HaltJul 30, 2025
  • Appendix 4C and Quarterly Activities Report - June 2025Jul 28, 2025

Later from Imagion Biosystems

  • Appendix 4C and Quarterly Activities Report - September 2025Oct 20, 2025
  • Positive Results Received from WSU on MagSense DosageNov 4, 2025
  • Positive Final WSU Trial Results To Support IND SubmissionDec 1, 2025
  • Mercer Convertible Securities Conversion and AmendmentJan 7
  • Appendix 4C and Quarterly Activities Report - December 2025Jan 28
All Imagion Biosystems news releases↗

Follow Imagion Biosystems into a list and get an email when it puts out news.

Follow Imagion Biosystems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer